The question was: "Given the uncertainty in overall survival, and availability of multiple therapies, is another trial needed to better characterize the risk:benefit profile of tivozanib before approval can be considered?"
So this is good for AVEO!
They changed the form of the question so that a "no" vote is negative for AVEO...this company is one dead monkey
so we are fine? ye$$$$$$$